Speed Reads
Solving COVID

U.K. begins large trial of new COVID-19 treatment inhaled into the lungs

Britain on Tuesday began a large-scale trial of a new COVID-19 treatment in which patients inhale aerosolized interferon beta proteins into the lungs with a nebulizer. The treatment, developed at Southampton University Hospital and produced by biotech firm Synairgen, cut the odds of COVID-19 patients developing severe symptoms by nearly 80 percent, according to a small, phase 2 trial of 100 patients. The new phase 3 study involves more than 600 subjects in 20 countries, half of whom will get the treatment and half a placebo inhalant.

ADVERTISEMENT: Article continues below

The body produces interferon beta to fight off viral infections, but the new coronavirus appears to suppress production of the proteins as part of its mechanism to evade patients' immune responses, BBC News reports. Synairgen hopes a direct shot of aerosolized interferon beta straight to the lungs will provoke a strong anti-viral response. The early results are promising, but experts warn that promising treatments don't always pan out.

"We've had other drugs in similar circumstances, we've had hydroxychloroquine, for example," Dr. Lamis Latif tells BBC News. "But again, when that reached further trials, it wasn't as promising as it initially made up to be.

Recommended

What happened to the coming recession?
Feature

What happened to the coming recession?

Americans are tired of quitting
Feature

Americans are tired of quitting

When will inflation come down?
Briefing

When will inflation come down?

The paradox of atmospheric cooling
Briefing

The paradox of atmospheric cooling

Most Popular

Ban the Bible?
Briefing

Ban the Bible?

Apple fixes its 'ducking' autocorrect problem
duck yeah

Apple fixes its 'ducking' autocorrect problem

DOJ reportedly tells Trump he's a target of criminal investigation
Famous Firsts

DOJ reportedly tells Trump he's a target of criminal investigation